Search research articles
Contact Us
Filters
Showing results (61-70 of 86) with videos related to
Page
of 9
Sort By:
Neuroimage
|
December 9, 2014
Partial volume correction in quantitative amyloid imaging
Yi Su, Tyler M Blazey, Abraham Z Snyder, et al.
Neuro-Oncology
|
March 11, 2020
AI-based prognostic imaging biomarkers for precision neuro-oncology: the ReSPOND consortium
Christos Davatzikos, Jill S Barnholtz-Sloan, Spyridon Bakas, et al.
Neurobiology of Disease
|
March 31, 2022
CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer disease
Jeremy F Strain, Nicolas Barthelemy, Kanta Horie, et al.
Brain : a Journal of Neurology
|
March 10, 2018
Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing
Jasmeer P Chhatwal, Aaron P Schultz, Keith A Johnson, et al.
Neurology
|
September 16, 2018
Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease
Eric McDade, Guoqiao Wang, Brian A Gordon, et al.
Ebiomedicine
|
October 22, 2024
Relationship between MRI brain-age heterogeneity, cognition, genetics and Alzheimer's disease neuropathology
Mathilde Antoniades, Dhivya Srinivasan, Junhao Wen, et al.
Annals of Neurology
|
March 27, 2016
White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network
Seonjoo Lee, Fawad Viqar, Molly E Zimmerman, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
November 13, 2018
Utility of perfusion PET measures to assess neuronal injury in Alzheimer's disease
Nelly Joseph-Mathurin, Yi Su, Tyler M Blazey, et al.
Brain : a Journal of Neurology
|
February 13, 2019
Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers
Brian A Gordon, Tyler M Blazey, Jon Christensen, et al.
Brain Connectivity
|
January 12, 2021
Resting-State Functional Connectivity Disruption as a Pathological Biomarker in Autosomal Dominant Alzheimer Disease
Robert X Smith, Jeremy F Strain, Aaron Tanenbaum, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 86) with videos related to
Sort By:
Page
of 9
Neuroimage
|
December 9, 2014
Partial volume correction in quantitative amyloid imaging
Yi Su, Tyler M Blazey, Abraham Z Snyder, et al.
Neuro-Oncology
|
March 11, 2020
AI-based prognostic imaging biomarkers for precision neuro-oncology: the ReSPOND consortium
Christos Davatzikos, Jill S Barnholtz-Sloan, Spyridon Bakas, et al.
Neurobiology of Disease
|
March 31, 2022
CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer disease
Jeremy F Strain, Nicolas Barthelemy, Kanta Horie, et al.
Brain : a Journal of Neurology
|
March 10, 2018
Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing
Jasmeer P Chhatwal, Aaron P Schultz, Keith A Johnson, et al.
Neurology
|
September 16, 2018
Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease
Eric McDade, Guoqiao Wang, Brian A Gordon, et al.
Ebiomedicine
|
October 22, 2024
Relationship between MRI brain-age heterogeneity, cognition, genetics and Alzheimer's disease neuropathology
Mathilde Antoniades, Dhivya Srinivasan, Junhao Wen, et al.
Annals of Neurology
|
March 27, 2016
White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network
Seonjoo Lee, Fawad Viqar, Molly E Zimmerman, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
November 13, 2018
Utility of perfusion PET measures to assess neuronal injury in Alzheimer's disease
Nelly Joseph-Mathurin, Yi Su, Tyler M Blazey, et al.
Brain : a Journal of Neurology
|
February 13, 2019
Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers
Brian A Gordon, Tyler M Blazey, Jon Christensen, et al.
Brain Connectivity
|
January 12, 2021
Resting-State Functional Connectivity Disruption as a Pathological Biomarker in Autosomal Dominant Alzheimer Disease
Robert X Smith, Jeremy F Strain, Aaron Tanenbaum, et al.
Page
of 9